Structural and Functional Analyses of the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir (S/GSK1349572) (original) (raw)

3 '-Processing and strand transfer catalysed by retroviral integrase in crystallo

EMBO Journal, 2012

Impact of Resistance Mutations on Inhibitor Binding to HIV‑1 Integrase

Characterization of the R263K Mutation in HIV-1 Integrase That Confers Low-Level Resistance to the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir

Mark Wainberg

Journal of Virology, 2012

View PDFchevron_right

Aromatic interaction profile to understand the molecular basis of raltegravir resistance

Tuniki Balaraju

Structural Chemistry, 2012

View PDFchevron_right

Integrase Strand Transfer Inhibitors as potential anti-HIV agent

GERF Bulletin of Biosciences

View PDFchevron_right

Molecular dynamic simulations to investigate the structural impact of known drug resistance mutations on HIV-1C Integrase-Dolutegravir binding

Adetayo Obasa

View PDFchevron_right

Unprocessed Viral DNA Could Be the Primary Target of the HIV-1 Integrase Inhibitor Raltegravir

Farah Ammar, Safwat S A Abdel-azeim

PLoS ONE, 2012

View PDFchevron_right

HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase

Amy Espeseth

Proceedings of the National Academy of Sciences, 2000

View PDFchevron_right

Modeling, Analysis, and Validation of a Novel HIV Integrase Structure Provide Insights into the Binding Modes of Potent Integrase Inhibitors

X. Qi

Journal of Molecular Biology, 2008

View PDFchevron_right

Biological and structural analysis of new potent Integrase-LEDGF allosteric HIV-1 inhibitors

Julien Batisse

View PDFchevron_right

Fueling HIV-1 integrase drug design with structural insights

Marc De Maeyer

Drug Discovery Today: Technologies, 2012

View PDFchevron_right

Structure-Analysis of the HIV-1 Integrase Y143C/R Raltegravir Resistance Mutation in Association with the Secondary Mutation T97A

Michel Laguerre

Antimicrobial Agents and Chemotherapy, 2011

View PDFchevron_right

Biochemical Analysis of the Role of G118R-Linked Dolutegravir Drug Resistance Substitutions in HIV-1 Integrase

Tamar Veres

Antimicrobial Agents and Chemotherapy, 2013

View PDFchevron_right

A computational overview of integrase strand transfer inhibitors (INSTIs) against emerging and evolving drug-resistant HIV-1 integrase mutants

Tareeka sonawane

Archives of Microbiology

View PDFchevron_right

Dolutegravir (S/GSK1349572) Exhibits Significantly Slower Dissociation than Raltegravir and Elvitegravir from Wild-Type and Integrase Inhibitor-Resistant HIV-1 Integrase-DNA Complexes

luke carter

Antimicrobial Agents and Chemotherapy, 2011

View PDFchevron_right

Probing Resistance Mutations in Retroviral Integrases by Direct Measurement of Dolutegravir Fluorescence

Eloïse THIERRY

Scientific reports, 2017

View PDFchevron_right

Investigation on the sucrose binding pocket of HIV-1 Integrase by molecular dynamics and synergy experiments

Francesca Esposito

Bioorganic & Medicinal Chemistry Letters, 2015

View PDFchevron_right

Changes to the HIV Long Terminal Repeat and to HIV Integrase Differentially Impact HIV Integrase Assembly, Activity, and the Binding of Strand Transfer Inhibitors

Mark Krystal

Journal of Biological Chemistry, 2007

View PDFchevron_right

An Unusual Helix Turn Helix Motif in the Catalytic Core of HIV-1 Integrase Binds Viral DNA and LEDGF

Richard Maroun

PLoS ONE, 2009

View PDFchevron_right

Induced-Fit Docking Approach Provides Insight into the Binding Mode and Mechanism of Action of HIV-1 Integrase Inhibitors

Nunzio Iraci

ChemMedChem, 2009

View PDFchevron_right

Crystal Structure of HIV‐1 Reverse Transcriptase Bound to a Non‐Nucleoside Inhibitor with a Novel Mechanism of Action

Marco Radi

Angewandte …, 2010

View PDFchevron_right

Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV1 reverse transcriptase inhibitors

kalyan das

Progress in Biophysics & Molecular Biology, 2005

View PDFchevron_right

A unique conformational escape reaction of HIV-1 against an allosteric integrase inhibitor

Masayuki Amano

View PDFchevron_right

Catalytically-active complex of HIV1 integrase with a viral DNA substrate binds anti-integrase drugs

Vicki Chiang

Proceedings of The National Academy of Sciences, 2009

View PDFchevron_right

HIV-1 integrase inhibitor T30177 forms a stacked dimeric G-quadruplex structure containing bulges

Anh Phan

Nucleic Acids Research, 2011

View PDFchevron_right

HIV1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation

Laura De Luca

European Journal of Medicinal Chemistry, 2011

View PDFchevron_right

Progress in HIV-1 Integrase Inhibitors: A Review of their Chemical Structure Diversity

zahra hajimahdi

Iranian journal of pharmaceutical research : IJPR, 2016

View PDFchevron_right

Roles of Conformational and Positional Adaptability in Structure-Based Design of TMC125-R165335 (Etravirine) and Related Non-nucleoside Reverse Transcriptase Inhibitors That Are Highly Potent and Effective against Wild-Type and Drug-Resistant HIV-1 Variants

Hong Ye, Kalyan Das

Journal of Medicinal Chemistry, 2004

View PDFchevron_right

Structural and Functional Analyses of the Second-Generation Integrase Strand Transfer Inhibitor Dolutegravir (S/GSK1349572) (original) (raw)

Related papers